Analyst Derek Archila of Wells Fargo maintained a Hold rating on Zentalis Pharmaceuticals (ZNTL – Research Report), with a price target ...
Zentalis Pharmaceuticals (ZNTL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback